TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Dose limited toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Lid Margin Evaluation: Number of Eyes With Abnormal Biomicroscopy Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of microorganisms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: In-hospital case-fatality
Endpoint domain: Mortality/survival
Primary endpoint: Mean Change From Baseline in Total Awake Time Spent Off
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Serum bactericidal activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cumulative CTCAE grade ≥ 4 SABR related toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: 2-year local recurrence rate
Endpoint domain: Mortality/survival
Primary endpoint: Premature birth
Endpoint domain: Mortality/survival
Primary endpoint: umbilical cord infection
Endpoint domain: Adverse events/effects
Primary endpoint: Horizontal Action Halo Diameter at 28 Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Horizontal Action Halo Diameter at 112 Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of screening and enrolling patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: length of stay at pediatric ward
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: change of Visual Analogue Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change of American Orthopaedic Foot and Ankle Society Ankle-Hindfoot Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of The Victorian Institute of Sport Assessment-Achilles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of The Achilles tendon Total Rupture Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of the Tegner Activity Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Biodex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With ALT Normalization Plus Negative HDV RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Percentage of analyzable GPS recordings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QTcF (ΔΔQTcF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Imaging markers for biochemical profiles in synovial fluid and cartilage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein changes at cytoplasmic and membrane protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Summed Rest Score (SRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Biomarkers value in the response to therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with controlled blood sugars
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients with controlled cholesterol profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: American Orthopedic Foot and Ankle Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: FOOT FUNCTION INDEX
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Low-frequency (LF)/High-frequency (HF) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Subjects With Adverse Drug Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Event-free Survival (EFS) Rate
Endpoint domain: Mortality/survival
Primary endpoint: LSCM examination results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score on the Montreal cognitive assessment (MOCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Development of urine leakage around the catheter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of cancer diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change of ATP concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of PCr concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of Pi concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concordance between CEUS and CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Support Care Needs Survey (SCNS) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Memorial Symptom Assessment Scale-Short Form (MSAS-SF) Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Functional Assessment of Cancer Therapy Scale-Breast Cancer (FACT-B) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Blood tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recall rate reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Number of Catheterizations Without Leaking Per Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nanosensory detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroresponse to Measles, Mumps, Rubella and Varicella
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum Bactericidal Titers ≥1:8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: hSBA ≥1:8 Following Two Doses of MenACWY-CRM Vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Peak plasma concentration (Cmax) of metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the plasma concentration versus time curve (AUC0-t) of atorvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the plasma concentration versus time curve (AUC0-t) of metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Occurrence of Disease Worsening or Death
Endpoint domain: Mortality/survival
Primary endpoint: Proinflammatory cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline in LDL-Cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in ApoB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in Small + Medium Sized LDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in Total Cholesterol/HDL Cholesterol ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pancreatic exocrine insufficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: POP-Q assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with adverse reactions at injection site
Endpoint domain: Adverse events/effects
Primary endpoint: Intratumour heterogeneity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Therapeutic Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Titer of Anti-Chikungunya Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: stress-related markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental area under the concentration curve (iAUC) of post-prandial glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overdose knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Overdose attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Medicated Diurnal Intra-ocular Pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC (area under the plasma concentration vs. time curve) for regorafenib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax (maximum drug concentration) for regorafenib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lequesne knee osteoarthritis questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percent change from baseline in total absolute surface depth of the central dimple/depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anti-HBs Seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Vaccination index assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative vitreous hemorrhage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Improvement in knee skin laxity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change from Baseline in Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in OSDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient preference in treatment therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Major Adverse Cardiac and Cerebrovascular Events
Endpoint domain: Adverse events/effects
Primary endpoint: Hepatic Progression-free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Website usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to First Appropriate Implantable Cardioverter Defibrillator (ICD) Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CD4 cell infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change From Baseline Child Body Fat Mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of new diagnoses of ipsilateral invasive cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of participants with Adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Time to reach full feeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Successful Discontinuation of Buprenorphine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stroke Impact Scale (SIS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EPB entrapment test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ultrasound examination of wrist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: platelet derived growth factor levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: endothelial cell growth factor levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-Month Median Progression Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: One year patient and graft survival
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of chronic allograft nephropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: HBVDNA levels ≤0 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device Usability and Utility Questionnaire Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sphincter urethral pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: 90-Day Re-hospitalization or Death
Endpoint domain: Mortality/survival
Primary endpoint: Calibrated Automated Thrombography (CAT) Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Acquisition of Any New Antibiotic-resistant Organism
Endpoint domain: Adverse events/effects
Primary endpoint: Switch from IgM to IgG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Grade of adverse events as assessed by CTCAE v4.0
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of adverse drug reactions (ADRs) and serious adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical efficacy by four grade (Response, Minor Response, No Response, and Indeterminable)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Youth Outcome Questionnaire-Self-report scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Neutrophil phagocytosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Catheter related thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Parental stress change from waitlist to start of intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in symptoms of stress, depression, and anxiety from waitlist to start of intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mindfulness change from waitlist to start of intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage Change of Dream Features Occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hearing loss at high frequencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Clinically Significant Changes in Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurance of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sleep quality of life indices
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Magnetic Resonance Imaging (MRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Memory and Attention task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change From Baseline to Week 24 in SIB Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Overall Change From Baseline in Modified CIBIC+ to Week 24
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Decreased urinary homogentisic acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Screening-to-enrollment ratio
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intervention adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Enjoyment of intervention activities
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes at Behavioral Inattention Test (BIT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes at KF-NAP scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Abscess healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Program engagement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Fugl Meyer Assessment (FMA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention of seal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Adherence to Carac®
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Hemispatial neglect scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect of OKS on vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of accurately interpreted photographs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Glomerular Filtration Rate (GFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Systolic arterial tension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Cognitive Function
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Whether client was able to receive services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Optimal Counseling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Received modern method
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Perceived patient centeredness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Humoral Immune Response (HI Antibodies)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of Smokers Prescribed Smoking Cessation Medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of abnormal Vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of abnormal Clinical laboratory tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of abnormal 12-lead digital electrocardiograms parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: clinical scoring (CS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visual analog scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cr/GFR improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: postoperative mortality/morbidity (within 30 days)
Endpoint domain: Mortality/survival
Primary endpoint: Rabies Virus Neutralizing Antibody Concentrations on Day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Reported a Local or Systemic Reaction After Any Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: distance walked in the 2 minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of calcipotriol in the stratum corneum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Amount of betamethasone dipropionate in the stratum corneum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Lowering LDL-C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Gut Microbial Translocation (iFABP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in Gut Microbial Translocation (Zonulin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in Gut Microbial Translocation (sCD14)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in Gut Microbial Translocation (sCD163)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: lung ultrasound score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of patients with confirmed tumor response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: change in PaO2/FiO2 measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change From Baseline in the Total Score of Performance of Upper Limb (PUL) 2.0 Version
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of remission determined by laparoscopy or laparotomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toxicity graded using the NCI CTC version 3.0
Endpoint domain: Adverse events/effects
Primary endpoint: Progression-free interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Outcome (Favorable Outcome Defined as Discharge Home, Without an Amputation, in Less Than the Median Hospital Stay for Survivors)
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline in Average Pain Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Well-Being Using the BREAST-Q, Reconstruction Module
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Cognitive Performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cortical bone tissue properties
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isometric Strength Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes